Status:
COMPLETED
The Effect of the Egg Shell Nanoparticles Combined With Titanium Dioxide Nanoparticles
Lead Sponsor:
Egymedicalpedia
Conditions:
Dentin Hypersensitivity
Eligibility:
All Genders
20-55 years
Phase:
PHASE1
Brief Summary
Dentin hypersensitivity is one of the most commonly occurring clinical dental conditions which is characterized by short and sharp pain which arises from exposed dentin in response to external stimuli...
Detailed Description
Dentin desensitizing products, containing agents such as fluoride, strontium salts, oxalate, glutaraldehyde and bioactive glass, are employed to treat dentin hypersensitivity. Based on the hydrodynam...
Eligibility Criteria
Inclusion
- 1- For patients;
- Age between 20 and 55 years
- Patients in good systemic health with clinically elicitable dentin hypersensitivity
- Absence of contraindications to the proposed therapies as allergy. 2 - For teeth;
- Absence of local pathologies (e.g., caries and fractures)
- Visual analog scale (VAS) score ≥3
Exclusion
- \-- For patients;
- Use of any desensitizing toothpaste for previous 3 or 4 months.
- Taking analgesics/anti-inflammatory drugs at the time of the study, pregnancy, and smoking.
- 2 -For teeth ;
- Teeth with abrasion and attrition.
- Carious lesions on the selected or neighboring teeth, defective restorations
- Any professional desensitizing therapy on the selected teeth during the last 6 months.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06025084
Start Date
December 1 2022
End Date
March 30 2023
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistary - Al-Azhar University
Cairo, Egypt